Merotate S 1.5GM Inj.
Merotate S 1.5 GM is an antibiotic injection containing Meropenem 1000 mg and Sulbactam 500 mg. It is formulated to support the management of certain serious bacterial infections under the supervision of a qualified healthcare professional. Meropenem is a broad-spectrum antibiotic that works by interfering with bacterial cell-wall formation, while Sulbactam helps protect the antibiotic from certain enzymes produced by bacteria. Together, this combination provides antibacterial coverage against a range of susceptible bacteria.
Merotate S 1.5 GM should be administered only when prescribed by a doctor and by trained healthcare professionals. It is not intended for treating viral infections such as the common cold or flu.
Criticine Care offers Merotate S 1.5 GM as part of its pharmaceutical product portfolio, supporting healthcare businesses looking for dependable products in the antibiotic and critical-care segment. With a focus on quality, reliable product availability, professional support, and business-oriented pharmaceutical solutions, Criticine Care aims to serve distributors, stockists, hospitals, healthcare institutions, and other B2B pharmaceutical partners.
Merotate S 1.5 GM can be a valuable addition to portfolios serving the critical-care and hospital-use segment. Businesses looking to source Meropenem and Sulbactam Injection PCD Pharma Franchise can explore Merotate S 1.5 GM from Criticine Care.
Disclaimer – This information is provided for general educational purposes only. Merotate S 1.5 GM should be used only under the direction of a qualified healthcare professional. The information does not replace professional medical advice, diagnosis, or treatment.
